Literature DB >> 8787836

Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites.

K Ishiguro1, K Sato, M Takamatsu, J Park, T Uchida, K Imahori.   

Abstract

Previously, we determined sites of tau protein phosphorylation by tau protein kinase (TPK) I/glycogen synthase kinase 3 beta (GSK-3 beta) and TPKII/(cyclin-dependent kinase 5 (CDK5) + p23). We prepared antibodies specific for these sites of tau phosphorylated by TPKI and TPKII, using chemically synthesized phosphopeptides as antigens. Each antibody specifically reacts with each phosphorylation site. With these antibodies, it was confirmed that TPKI and TPKII are responsible for these phosphorylation sites, as reported previously, except that Ser404 is also weakly phosphorylated by TPKI alone. It was also observed that TPKII-phosphorylation enhances TPKI-phosphorylation. These results indicate that these antibodies are useful tools for investigation of the phosphorylation of tau by TPKI and TPKII.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8787836     DOI: 10.1016/0304-3940(95)12206-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

2.  Cholinergic Grb2-Associated-Binding Protein 1 Regulates Cognitive Function.

Authors:  Nan-Nan Lu; Chao Tan; Ning-He Sun; Ling-Xiao Shao; Xiu-Xiu Liu; Yin-Ping Gao; Rong-Rong Tao; Quan Jiang; Cheng-Kun Wang; Ji-Yun Huang; Kui Zhao; Guang-Fa Wang; Zhi-Rong Liu; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Cereb Cortex       Date:  2018-07-01       Impact factor: 5.357

Review 3.  Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.

Authors:  Varsha Shukla; Susan Skuntz; Harish C Pant
Journal:  Arch Med Res       Date:  2012-11-07       Impact factor: 2.235

4.  Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.

Authors:  Masaki Ikeda; Mikio Shoji; Toshitaka Kawarai; Takeshi Kawarabayashi; Etsuro Matsubara; Tetsuro Murakami; Atsushi Sasaki; Yasushi Tomidokoro; Yasushi Ikarashi; Hisashi Kuribara; Koichi Ishiguro; Masato Hasegawa; Shu-Hui Yen; M Azhar Chishti; Yasuo Harigaya; Koji Abe; Koichi Okamoto; Peter St George-Hyslop; David Westaway
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities.

Authors:  Sarah L Lambourne; Lynda A Sellers; Toby G Bush; Shewly K Choudhury; Piers C Emson; Yoo-Hun Suh; Lawrence S Wilkinson
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

6.  Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau.

Authors:  A Takashima; M Murayama; O Murayama; T Kohno; T Honda; K Yasutake; N Nihonmatsu; M Mercken; H Yamaguchi; S Sugihara; B Wolozin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by proteasome-mediated degradation of p35 cyclin-dependent kinase 5 activator.

Authors:  Ryo Endo; Taro Saito; Akiko Asada; Hiroyuki Kawahara; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

Review 8.  Discovery of compounds that will prevent tau pathology.

Authors:  Kenneth S Kosik; Jae Ahn; Ross Stein; Li-An Yeh
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

9.  Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

Authors:  Emmanuel Planel; Tomohiro Miyasaka; Thomas Launey; De-Hua Chui; Kentaro Tanemura; Shinji Sato; Ohoshi Murayama; Koichi Ishiguro; Yoshitaka Tatebayashi; Akihiko Takashima
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

10.  Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites.

Authors:  Taeko Kimura; Koji Tsutsumi; Masato Taoka; Taro Saito; Masami Masuda-Suzukake; Koichi Ishiguro; Florian Plattner; Takafumi Uchida; Toshiaki Isobe; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.